Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $436 Million. The most recent transaction as insider was on Feb 25, 2020, when has been sold 5,286 shares (Common Stock) at a price of $23.0 per share, resulting in proceeds of $121,578. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M
0.49% 3M change
1.39% 12M change
Total Value Held $436 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2020
SELL
Open market or private sale
$121,578 $23.0 p/Share
5,286 Reduced 0.08%
6,722,648 Common Stock
Feb 18 2020
SELL
Bona fide gift
-
5,000 Reduced 0.07%
6,727,934 Common Stock
Feb 10 2020
SELL
Open market or private sale
$101,120 $23.5 p/Share
4,303 Reduced 0.06%
6,732,934 Common Stock
Feb 07 2020
SELL
Open market or private sale
$112,148 $23.0 p/Share
4,876 Reduced 0.07%
6,737,237 Common Stock
Jan 22 2020
SELL
Open market or private sale
$354,154 $23.0 p/Share
15,398 Reduced 0.23%
6,742,113 Common Stock
Jan 15 2020
SELL
Bona fide gift
-
4,989 Reduced 0.07%
6,757,511 Common Stock
Dec 09 2019
BUY
Other acquisition or disposition
-
42,132 Added 0.62%
6,762,500 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA